Glenn joined Evaxion in October of 2019. Prior to joining our company, he served as Chief Financial Officer of electroCore, Inc. from August 2016 until April of 2019 and was a key member of the management team that carried the company through a successful IPO in June of 2018.
Prior to that, from February 2014 to January 2016, Glenn served as Chief Financial Officer at G&W Laboratories, Inc., a specialty pharmaceutical company, where he executed the growth strategy by acquiring two companies and over 35 products.